× Key messages Background Findings Perspectives Expert commentary

Patient selection for CGRP-targeted monoclonal antibody prevention

Key messages

  • Access to migraine prevention treatment is influenced by sociodemographic factors and less than a third of people requiring treatment are receiving it.
  • Empirical research is required to improve access to preventative treatments and to inform the revision of the AHS Position Statement.